Marijuana in the management of amyotrophic lateral sclerosis       (abst – 2001) t=cannabis&searchid=1&FIRSTINDEX=1200&resourcetype=HWCIT


Survey of cannabis use in patients with amyotrophic lateral sclerosis.     (abst – 2004)



Delayed disease progression in ALS mice by treatment with a cannabinoid.   (abst – 2004)


Cannabis’ Potential Exciting Researchers in Treatment of ALS, Parkinson’s Disease – URB597                    (news – 2004)


Cannabis Relieves Lou Gehrigs Symptoms – New Study      (news – 2004)


Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain                                (news – 2004)


Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.                       (abst – 2005) 0


Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice                                 (full – 2006)


AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis.                                       (abst – 2006)


The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset                                 (full – 2007)


The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full – 2007)  ry_neuro.pdf


Cannabinoids and neuroprotection in motor-related disorders.       (abst – 2007)


The (Endo)Cannabinoid System in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst – 2007)                  


The endocannabinoid system in amyotrophic lateral sclerosis.        (abst – 2008)


Altered presymptomatic AMPA and cannabinoid receptor trafficking in motor neurons of ALS model mice: implications for excitotoxicity.                                    (abst – 2008)


Role of CB2 receptors in neuroprotective effects of cannabinoids.     (abst – 2008)


Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects                       (full – 2009)


Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full – 2009)               


Cannabinoids and neurodegenerative diseases.      (abst – 2009)


Medical Marijuana and Amyotrophic Lateral Sclerosis (ALS)         (news – 2009)


Medical Marijuana and Lou Gehrig’s Disease         (news – 2009)


Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials.                            (abst – 2010)


The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis.                       (abst – 2010)


Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis.                              (abst – 2010)


The endocannabinoid system in gp120-mediated insults and HIV-associated dementia. (abst – 2010)                    


Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial.                               (abst – 2010)


Marijuana May Extend Life Expectancy Of Lou Gehrig’s Disease Patients, Study Says (news – 2010)                     


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                     


Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis.                               (abst – 2012)


Medical Cannabis Helps ALS Patient Outlive her Own Doctors (news/anecdotal – 2012)




Share a link for